CTKBHealthcareSmall-Cap

Cytek Biosciences, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for Cytek Biosciences, Inc. (CTKB), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are CTKB insiders buying or selling?

Cytek Biosciences, Inc. insiders reported 14 open-market buys ($100.5M) and 66 sells ($10.6M) across 80 Form 4 filings — a net buying position of $89.9M.

Source: SEC EDGAR Form 4

Key Statistics (as of Jun 3, 2025)

Total Form 4 filings
80
SEC EDGAR
Insider filers
9
Insider buys (14)
$100.5M
Insider sells (66)
$10.6M

Insider sentiment

Net buying

Net insider flow of $89.9M in net buying.

Recent CTKB insider transactions

DateInsiderRoleTypeSharesPriceValue
Jun 3, 2025William D. MccombeChief Financial OfficerPurchase35.0K$2.78$97.3K
Apr 23, 2024Ming YanCHIEF TECHNOLOGY OFFICERSale20.0K$5.87$117.4K
Apr 11, 2024Ming YanCHIEF TECHNOLOGY OFFICERSale1.9K$7.00$13.3K
Mar 19, 2024Ming YanCHIEF TECHNOLOGY OFFICERSale40.0K$6.74$269.6K
Dec 27, 2023Patrik JeanmonodChief Financial OfficerSale3.0K$9.50$28.5K
Dec 21, 2023Ming YanChief Technology OfficerSale20.0K$9.43$188.6K
Nov 28, 2023Patrik JeanmonodChief Financial OfficerSale3.0K$6.94$20.8K
Nov 21, 2023Ming YanChief Technology OfficerSale20.0K$6.03$120.6K
Nov 8, 2023Jiang WenbinPresident and CEOSale20.0K$4.34$86.8K
Oct 25, 2023Patrik JeanmonodChief Financial OfficerSale3.0K$4.68$14.0K
Oct 24, 2023Ming YanChief Technology OfficerSale20.0K$4.80$96.0K
Oct 11, 2023Jiang WenbinPresident and CEOSale20.0K$5.33$106.6K
Sep 26, 2023Patrik JeanmonodChief Financial OfficerSale3.0K$6.38$19.1K
Sep 20, 2023Ming YanChief Technology OfficerSale20.0K$6.49$129.8K
Sep 8, 2023Jiang WenbinPresident and CEOSale20.0K$6.83$136.6K
Aug 28, 2023Patrik JeanmonodChief Financial OfficerSale3.0K$7.69$23.1K
Aug 22, 2023Ming YanChief Technology OfficerSale20.0K$8.07$161.4K
Aug 9, 2023Jiang WenbinPresident and CEOSale20.0K$9.04$180.8K
Jul 25, 2023Patrik JeanmonodChief Financial OfficerPurchase3.0K$9.17$27.5K
Jul 20, 2023Ming YanChief Technology OfficerSale20.0K$8.76$175.2K
Jul 8, 2023Jiang WenbinPresident and CEOSale20.0K$8.48$169.6K
Jun 27, 2023Patrik JeanmonodChief Financial OfficerSale3.0K$7.96$23.9K
Jun 21, 2023Ming YanChief Technology OfficerSale20.0K$8.18$163.6K
Jun 7, 2023Jiang WenbinPresident and CEOSale20.0K$8.23$164.6K
May 25, 2023Patrik JeanmonodChief Financial OfficerSale3.0K$7.76$23.3K

Showing the 25 most recent of 80 Form 4 filings for Cytek Biosciences, Inc..

Most active CTKB insiders

  • Ming Yan29 filings
  • Jiang Wenbin21 filings
  • Patrik Jeanmonod16 filings
  • Peter Kolchinsky8 filings
  • Jack Ball2 filings

Ask anything about CTKB insider activity

Use Trabud's AI agent to query Cytek Biosciences, Inc.'s Form 4 history in plain English — "Show me CTKB CEO purchases this year" or compare it against any other ticker.

Open the AI agent

CTKB insider trading FAQ

Are Cytek Biosciences, Inc. insiders buying or selling?

Across 80 SEC Form 4 filings, Cytek Biosciences, Inc. (CTKB) insiders reported 14 open-market purchases totaling $100.5M and 66 sales totaling $10.6M. That is a net buying position of $89.9M.

How many insiders trade CTKB stock?

9 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Cytek Biosciences, Inc.. The most recent filing was accepted on Jun 3, 2025.

Where does Trabud get CTKB insider trading data?

All CTKB insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content